Skip to main content
ATOSSA THERAPEUTICS, INC. logo

ATOSSA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · ATOS ISIN · US04962H5063 US Manufacturing
Open in API
Filings indexed 622 across all filing types
Latest filing 2018-05-31 Director's Dealing
Country US United States of America
Listing US ATOS

About ATOSSA THERAPEUTICS, INC.

https://atossatherapeutics.com/

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative medicines for areas of significant unmet medical need, with a primary focus on oncology. The company is dedicated to addressing the full continuum of breast cancer care. Its lead program is centered on (Z)-endoxifen, a proprietary and potent selective estrogen receptor modulator (SERM). Atossa is advancing (Z)-endoxifen through clinical development for multiple breast cancer indications, including metastatic disease, aiming to provide a therapeutic with a potentially improved efficacy and tolerability profile.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2018-05-31 English
OWNERSHIP DOCUMENT
Director's Dealing
2018-05-31 English
FORM 8K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes details about the creation of a new series of preferred stock (Series B Convertible Preferred Stock), amendments to articles of incorporation, completion of a rights offering, and related agreements. It does not contain comprehensive financial statements or detailed financial performance data typical of annual or quarterly reports. Instead, it reports on corporate actions related to capital structure and securities issuance. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length (8631 characters) and detailed description of the rights offering and stock issuance support this classification with high confidence.
2018-05-31 English
FORM 8K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 14, 2018, reporting the issuance of a press release announcing first quarter 2018 financial results and a company update. The text explicitly states that the press release is attached as Exhibit 99.1 and incorporated by reference. The document itself does not contain detailed financial statements or substantive financial data but rather announces the release of such information. The length of the document is 3169 characters, which is relatively short and consistent with an announcement rather than a full report. According to the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and includes Form 8-K filings announcing press releases.
2018-05-17 English
FWP
Investor Presentation Classification · 95% confidence The document is titled 'Issuer Free Writing Prospectus' and is filed pursuant to Rule 433, relating to a prospectus dated May 10, 2018, with a registration statement number provided. It contains detailed corporate presentation information including company mission, management, drug programs, clinical trial phases, market opportunities, and upcoming milestones. The content is promotional and informative about the company's securities offering and business strategy, typical of a prospectus or investor presentation. It is not a full financial report, audit report, or regulatory filing. The document is lengthy (over 14,000 characters) and contains detailed presentation slides and forward-looking statements. This matches the description of an Investor Presentation (IP) rather than a formal prospectus or regulatory filing. Therefore, the best classification is Investor Presentation (IP).
2018-05-16 English
FORM 10-Q
Interim / Quarterly Report Q1 2018
2018-05-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.